Martin Robert Chasen1, Ravi Bhargava. 1. Gerald Bronfman Centre for Clinical Research in Oncology, McGill University, 546 Pine Avenue West, Montreal, QC H2W 1S6, Canada. martin.chasen@mcgill.ca
Abstract
PURPOSE: Gastroesophageal carcinoma has a 5-year survival rate of 20%. Esophagogastrectomy is a significant life-altering operation which interferes with a patient's ability to eat food as a normal social interaction. Dumping syndrome, delayed gastric emptying, and reflux are encountered after surgery. In addition, loss of appetite and body weight occurs. Fatigue is universally encountered. We conducted this study to evaluate whether a structured cancer nutrition and rehabilitation program has an effect on the symptoms and quality of life of patients with gastroesophageal cancer. MATERIALS AND METHODS: Fifty-three patients with histologically documented gastroesophageal carcinoma were evaluated before and after an 8-week multidisciplinary program consisting of physicians, oncology nurse, dietitian, physical and occupational therapists, social worker, and psychologist. Twenty-two patients completed all the following questionnaires pre- and post-program: The Edmonton Symptom Assessment Scale (ESAS), Patient-Generated Subjective Global Assessment (PG-SGA), Brief Fatigue Inventory (BFI), and the Distress Thermometer. RESULT: There were 42 male and 11 female patients. The median age was 63 years (22-80 years). Thirty patients had gastric cancer and 23 had esophageal cancer. On the ESAS, appetite, strength, shortness of breath, and constipation all improved (p = 0.01). The PG-SGA score decreased significantly (p = 0.05). Fatigue and general activity as measured on the BFI improved significantly. The 6-min walk increased from 384 to 435 m (p = 0.01). CONCLUSION: The Cancer Nutrition and Rehabilitation program offers a multidimensional, holistic treatment approach emphasizing the patient as an individual. Participation in a cancer rehabilitation program ameliorates symptoms, improves nutrition, decreases global distress, and increases physical activities.
PURPOSE:Gastroesophageal carcinoma has a 5-year survival rate of 20%. Esophagogastrectomy is a significant life-altering operation which interferes with a patient's ability to eat food as a normal social interaction. Dumping syndrome, delayed gastric emptying, and reflux are encountered after surgery. In addition, loss of appetite and body weight occurs. Fatigue is universally encountered. We conducted this study to evaluate whether a structured cancer nutrition and rehabilitation program has an effect on the symptoms and quality of life of patients with gastroesophageal cancer. MATERIALS AND METHODS: Fifty-three patients with histologically documented gastroesophageal carcinoma were evaluated before and after an 8-week multidisciplinary program consisting of physicians, oncology nurse, dietitian, physical and occupational therapists, social worker, and psychologist. Twenty-two patients completed all the following questionnaires pre- and post-program: The Edmonton Symptom Assessment Scale (ESAS), Patient-Generated Subjective Global Assessment (PG-SGA), Brief Fatigue Inventory (BFI), and the Distress Thermometer. RESULT: There were 42 male and 11 female patients. The median age was 63 years (22-80 years). Thirty patients had gastric cancer and 23 had esophageal cancer. On the ESAS, appetite, strength, shortness of breath, and constipation all improved (p = 0.01). The PG-SGA score decreased significantly (p = 0.05). Fatigue and general activity as measured on the BFI improved significantly. The 6-min walk increased from 384 to 435 m (p = 0.01). CONCLUSION: The Cancer Nutrition and Rehabilitation program offers a multidimensional, holistic treatment approach emphasizing the patient as an individual. Participation in a cancer rehabilitation program ameliorates symptoms, improves nutrition, decreases global distress, and increases physical activities.
Authors: Jan B F Hulscher; Johanna W van Sandick; Angela G E M de Boer; Bas P L Wijnhoven; Jan G P Tijssen; Paul Fockens; Peep F M Stalmeier; Fiebo J W ten Kate; Herman van Dekken; Huug Obertop; Hugo W Tilanus; J Jan B van Lanschot Journal: N Engl J Med Date: 2002-11-21 Impact factor: 91.245
Authors: B Gagnon; J Murphy; M Eades; J Lemoignan; M Jelowicki; S Carney; S Amdouni; P Di Dio; M Chasen; N Macdonald Journal: Curr Oncol Date: 2013-12 Impact factor: 3.677
Authors: Eleonora Pinto; Alessandro Fabbian; Rita Alfieri; Anna Da Roit; Salvatore Marano; Genny Mattara; Pierluigi Pilati; Carlo Castoro; Marco Cavarzan; Marta Silvia Dalla Riva; Luisa Orrù; Gian Piero Turchi Journal: Behav Sci (Basel) Date: 2022-04-09
Authors: Martin Wagner; Pascal Probst; Michael Haselbeck-Köbler; Johanna M Brandenburg; Eva Kalkum; Dominic Störzinger; Jens Kessler; Joe J Simon; Hans-Christoph Friederich; Michaela Angelescu; Adrian T Billeter; Thilo Hackert; Beat P Müller-Stich; Markus W Büchler Journal: Ann Surg Date: 2022-01-27 Impact factor: 13.787
Authors: Roisin Tully; Lisa Loughney; Jarlath Bolger; Jan Sorensen; Oliver McAnena; Chris G Collins; Paul A Carroll; Mayilone Arumugasamy; Tomas J Murphy; William B Robb Journal: Trials Date: 2020-07-13 Impact factor: 2.279
Authors: Charlie C Hall; Jane Cook; Matthew Maddocks; Richard J E Skipworth; Marie Fallon; Barry J Laird Journal: Support Care Cancer Date: 2019-04-03 Impact factor: 3.603
Authors: Jawairia Latif; C Elizabeth Weekes; Anna Julian; Gary Frost; Jane Murphy; Yessica Abigail Tronco-Hernandez; Mary Hickson Journal: Clin Nutr ESPEN Date: 2021-11-19